These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Montelukast during primary infection prevents airway hyperresponsiveness and inflammation after reinfection with respiratory syncytial virus. Han J; Jia Y; Takeda K; Shiraishi Y; Okamoto M; Dakhama A; Gelfand EW Am J Respir Crit Care Med; 2010 Aug; 182(4):455-63. PubMed ID: 20442434 [TBL] [Abstract][Full Text] [Related]
4. Building a better neonatal mouse model to understand infant respiratory syncytial virus disease. You D; Siefker DT; Shrestha B; Saravia J; Cormier SA Respir Res; 2015 Aug; 16(1):91. PubMed ID: 26231396 [TBL] [Abstract][Full Text] [Related]
5. Pulmonary hypertension during respiratory syncytial virus bronchiolitis: a risk factor for severity of illness. Kimura D; McNamara IF; Wang J; Fowke JH; West AN; Philip R Cardiol Young; 2019 May; 29(5):615-619. PubMed ID: 31104634 [TBL] [Abstract][Full Text] [Related]
6. Increased airway reactivity in human RSV bronchiolitis in the guinea pig is not due to increased wall thickness. Robinson PJ; Hegele RG; Schellenberg RR Pediatr Pulmonol; 1996 Oct; 22(4):248-54. PubMed ID: 8905885 [TBL] [Abstract][Full Text] [Related]
7. Severity of respiratory syncytial virus bronchiolitis is affected by cigarette smoke exposure and atopy. Bradley JP; Bacharier LB; Bonfiglio J; Schechtman KB; Strunk R; Storch G; Castro M Pediatrics; 2005 Jan; 115(1):e7-14. PubMed ID: 15629968 [TBL] [Abstract][Full Text] [Related]
9. Persistence of respiratory syncytial virus (RSV) infection and development of RSV-specific IgG1 response in a guinea-pig model of acute bronchiolitis. Dakhama A; Vitalis TZ; Hegele RG Eur Respir J; 1997 Jan; 10(1):20-6. PubMed ID: 9032486 [TBL] [Abstract][Full Text] [Related]
10. The complex relationship between respiratory syncytial virus and allergy in lung disease. Peebles RS; Hashimoto K; Graham BS Viral Immunol; 2003; 16(1):25-34. PubMed ID: 12725686 [TBL] [Abstract][Full Text] [Related]
11. IL-4Rα on dendritic cells in neonates and Th2 immunopathology in respiratory syncytial virus infection. Shrestha B; You D; Saravia J; Siefker DT; Jaligama S; Lee GI; Sallam AA; Harding JN; Cormier SA J Leukoc Biol; 2017 Jul; 102(1):153-161. PubMed ID: 28389622 [TBL] [Abstract][Full Text] [Related]
12. An immunocompromised BALB/c mouse model for respiratory syncytial virus infection. Kong X; Hellermann GR; Patton G; Kumar M; Behera A; Randall TS; Zhang J; Lockey RF; Mohapatra SS Virol J; 2005 Feb; 2():3. PubMed ID: 15701174 [TBL] [Abstract][Full Text] [Related]
13. Enhanced IL-4 responses in children with a history of respiratory syncytial virus bronchiolitis in infancy. Pala P; Bjarnason R; Sigurbergsson F; Metcalfe C; Sigurs N; Openshaw PJ Eur Respir J; 2002 Aug; 20(2):376-82. PubMed ID: 12212970 [TBL] [Abstract][Full Text] [Related]
14. Serum KL-6 levels as a biomarker of lung injury in respiratory syncytial virus bronchiolitis. Kawasaki Y; Aoyagi Y; Abe Y; Go H; Imamura T; Kaneko M; Ito M; Katayose M; Hashimoto K; Hosoya M J Med Virol; 2009 Dec; 81(12):2104-8. PubMed ID: 19856476 [TBL] [Abstract][Full Text] [Related]
15. Flt3 ligand improves the innate response to respiratory syncytial virus and limits lung disease upon RSV reexposure in neonate mice. Remot A; Descamps D; Jouneau L; Laubreton D; Dubuquoy C; Bouet S; Lecardonnel J; Rebours E; Petit-Camurdan A; Riffault S Eur J Immunol; 2016 Apr; 46(4):874-84. PubMed ID: 26681580 [TBL] [Abstract][Full Text] [Related]
16. Exposure of neonates to respiratory syncytial virus is critical in determining subsequent airway response in adults. You D; Becnel D; Wang K; Ripple M; Daly M; Cormier SA Respir Res; 2006 Aug; 7(1):107. PubMed ID: 16893457 [TBL] [Abstract][Full Text] [Related]
17. Respiratory Syncytial Virus (RSV) Pulmonary Infection in Humanized Mice Induces Human Anti-RSV Immune Responses and Pathology. Sharma A; Wu W; Sung B; Huang J; Tsao T; Li X; Gomi R; Tsuji M; Worgall S J Virol; 2016 May; 90(10):5068-5074. PubMed ID: 26962219 [TBL] [Abstract][Full Text] [Related]
18. Viral-mediated inhibition of antioxidant enzymes contributes to the pathogenesis of severe respiratory syncytial virus bronchiolitis. Hosakote YM; Jantzi PD; Esham DL; Spratt H; Kurosky A; Casola A; Garofalo RP Am J Respir Crit Care Med; 2011 Jun; 183(11):1550-60. PubMed ID: 21471094 [TBL] [Abstract][Full Text] [Related]
19. Dual proinflammatory and antiviral properties of pulmonary eosinophils in respiratory syncytial virus vaccine-enhanced disease. Su YC; Townsend D; Herrero LJ; Zaid A; Rolph MS; Gahan ME; Nelson MA; Rudd PA; Matthaei KI; Foster PS; Dent L; Tripp RA; Lee J; Simson L; Mahalingam S J Virol; 2015 Feb; 89(3):1564-78. PubMed ID: 25410867 [TBL] [Abstract][Full Text] [Related]
20. Adult asthma after non-respiratory syncytial virus bronchiolitis in infancy: subgroup analysis of the 20-year prospective follow-up study. Piippo-Savolainen E; Korppi M; Korhonen K; Remes S Pediatr Int; 2007 Apr; 49(2):190-5. PubMed ID: 17445037 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]